Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy

ClinicalTrials.gov ID: NCT00224068

Public ClinicalTrials.gov record NCT00224068. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 2:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Controlled Prospective Trial of the Safety and Efficacy of Ferrlecit® in Anemic Cancer Patients Who Are Receiving Acute Chemotherapy and Epoetin as Compared to Oral Iron and No Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study evaluates the safety and efficacy of Ferrlecit® (ferric gluconate; a form of intravenous iron) or ferrous sulfate (a form of oral iron) in improving the response to epoetin alfa among anemic cancer patients receiving chemotherapy.

Study identification

NCT ID
NCT00224068
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Watson Pharmaceuticals
Industry
Enrollment
180 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2002 (Type not available)
Primary completion
Dec 2003 (Actual)
Completion
Dec 2003 (Actual)
Last update posted
Mar 2, 2012

2002 – 2003

United States locations

U.S. sites
32
U.S. states
22
U.S. cities
32
Facility City State ZIP Site status
Not listed Bakersfield California — —
Not listed Chula Vista California — —
Not listed Long Beach California — —
Not listed Los Angeles California — —
Not listed Norwich Connecticut — —
Not listed Port Saint Lucie Florida — —
Not listed Zephyrhills Florida — —
Not listed Columbus Georgia — —
Not listed Coeur d'Alene Idaho — —
Not listed Hutchinson Kansas — —
Not listed Lexington Kentucky — —
Not listed Baton Rouge Louisiana — —
Not listed Baltimore Maryland — —
Not listed Detroit Michigan — —
Not listed Saint Joseph Michigan — —
Not listed Southfield Michigan — —
Not listed Duluth Minnesota — —
Not listed Greenwood Mississippi — —
Not listed Cherry Hill New Jersey — —
Not listed Denville New Jersey — —
Not listed Manhasset New York — —
Not listed Bismarck North Dakota — —
Not listed Columbus Ohio — —
Not listed Philadelphia Pennsylvania — —
Not listed Pittsburgh Pennsylvania — —
Not listed West Chester Pennsylvania — —
Not listed Columbia South Carolina — —
Not listed Laredo Texas — —
Not listed Richmond Virginia — —
Not listed Salem Virginia — —
Not listed Walla Walla Washington — —
Not listed Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00224068, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2012 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00224068 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →